Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act

Pharmaceutical Executive Daily: Treasury Issues Notice to Add Biotech into Proposed COINS Act

Published 3 weeks, 5 days ago
Description
Treasury proposes adding biotechnology to its Outbound Investment Security Program, a pharma funding roundup covers Gilead’s $1.275 billion acquisition of an oral IL-23R inhibitor from PepStar and Zymeworks’ licensing deal with Roche, and Incubate’s John Stanford on why MFN is an offer pharma can’t refuse.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us